{"id":"W4292999428","doi":"10.54097/hset.v8i.1182","title":"T Recent advances of FDA-approved CAR-T therapies in multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Highlights in Science Engineering and Technology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multiple myeloma; Clinical trial; Intensive care medicine; Drug; Cytokine release syndrome; Adverse effect; Refractory (planetary science); Cancer; Oncology; Chimeric antigen receptor; Internal medicine; Pharmacology; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005066449,0.00009336667,0.0002356621,0.001324831,0.00007128165,0.000006033949,0.0002481213,0.00005252818,0.00005909132],"category_scores_gemma":[0.000169977,0.00008072489,0.00001460533,0.002510201,0.0004234074,0.00007163881,0.0001810458,0.0003113449,0.000001281298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000150163,"about_ca_system_score_gemma":0.00009020577,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002173417,"about_ca_topic_score_gemma":0.0000351253,"domain_scores_codex":[0.9988532,0.00001352407,0.0002011258,0.0002994285,0.0003097983,0.0003229216],"domain_scores_gemma":[0.999543,0.0000701799,0.0000321101,0.0002649536,0.00004964655,0.00004014589],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007183323,0.000108283,0.01367471,0.00003460946,0.00000695144,0.00004851614,0.0007241558,0.001029565,0.8951289,0.00727065,0.000008051236,0.08189374],"study_design_scores_gemma":[0.00308755,0.0009825331,0.02319334,0.0001042254,0.000006255648,0.0001558919,0.002257312,0.0201704,0.4224449,0.0007641608,0.5265043,0.0003291648],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913207,0.00543704,0.00002173653,0.002512414,0.0001502699,0.0002426553,0.000002537543,0.00007745245,0.0002351756],"genre_scores_gemma":[0.9955319,0.003145232,0.001073507,0.00001072777,0.00001132259,0.00008405514,8.643854e-7,0.000009765748,0.000132589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5264962,"threshold_uncertainty_score":0.3291865,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01480405433815957,"score_gpt":0.2646541526569917,"score_spread":0.2498500983188321,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}